_5.jpg)
BioPharma Beat: We Want Healthcare at Any Price – Until We Have It
We all know the expression, “We often don’t appreciate things until they…
Digital Tools in Pharma: An Interview with Panos Papakonstantinou
Papos Papakonstantinou of Novartis Europe, digital specialist, will be speaking at Doctors…
Venture Capital Fantasyland: Venrock’s Proposal to Reform Drug Development
Here come the dancers one by one,Your mamas calling but you’re having…
FDA Perspective on Rare Diseases
Rich Moscicki, M.D., Deputy Center Director for Science Operations, FDA spoke to…
Beyond the C-Suite: 3 Ways to Build Customer Focus
One of the most encouraging signs of progress in Pharma is the…
Interview with Paul Tunnah Founder of Pharmaphorum
Paul Tunnah is the CEO and Founder of pharmaphorum media. He received…
Prescription Drugs in the United States [INFOGRAPHIC]
Here's a great infographic about prescription drugs in the United States. Some…
Zohydro Ban: Disagreeing with Governor Patrick
Massachusetts Governor Deval Patrick is trying to ban Zohydro ER, a new…
Chief Customer Officers: Fancy New Title or Path to Meaningful Change?
Now that health reform seems here to stay, pharma companies are racing…
Hooray for High-Priced Hepatitis Treatment Sovaldi
Congratulations to Gilead Sciences for producing Sovaldi (sofosbuvir), which cures hepatitis C…